Skip to main content
logo
Mayne Pharma Group Limited (ASX:MYX)
Australia flag Australia · Delayed Price · Currency is AUD
2.570
-0.020 (-0.77%)
Apr 24, 2026, 4:11 PM AEST

Mayne Pharma Group Revenue

Mayne Pharma Group had revenue of 212.07M AUD in the half year ending December 31, 2025, with 12.85% growth. This brings the company's revenue in the last twelve months to 407.11M, down -1.55% year-over-year. In the fiscal year ending June 30, 2025, Mayne Pharma Group had annual revenue of 408.10M with 5.07% growth.

Revenue (ttm)
407.11M
Revenue Growth
-1.55%
P/S Ratio
0.51
Revenue / Employee
829.15K
Employees
491
Market Cap
208.80M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2025408.10M19.70M5.07%
Jun 30, 2024388.40M204.81M111.56%
Jun 30, 2023183.59M26.44M16.82%
Jun 30, 2022157.15M-243.63M-60.79%
Jun 30, 2021400.78M-56.20M-12.30%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.10B
Sonic Healthcare10.42B
Sigma Healthcare9.55B
Paragon Care3.67B
Pro Medicus240.57M
Aroa Biosurgery79.26M
Orthocell9.33M
Dimerix7.42M
Revenue Rankings

Mayne Pharma Group News

More News